AxoGen (AXGN) : Pennsylvania Trust Co reduced its stake in AxoGen by 30.31% during the most recent quarter end. The investment management company now holds a total of 131,365 shares of AxoGen which is valued at $1,145,503 after selling 57,133 shares in AxoGen , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.AxoGen makes up approximately 0.09% of Pennsylvania Trust Co’s portfolio.
Other Hedge Funds, Including , Cutler Group Lp added AXGN to its portfolio by purchasing 1,587 company shares during the most recent quarter which is valued at $14,362.Bnp Paribas Arbitrage Sa boosted its stake in AXGN in the latest quarter, The investment management firm added 847 additional shares and now holds a total of 1,801 shares of AxoGen which is valued at $15,218.
AxoGen (AXGN) witnessed a volatile trading activity on Friday , and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $8.56 and reached the intraday high at $8.75. The bulls started the profit booking and pushed the shares to intraday low of $8.3. The trading session was marked by a volume range of 2,92,026 shares exchanging hands. The 52-week high of the shares is $9.88 and the 52-week low is $4.08. The market cap of the company stands at $263 M and there are 3,01,32,224 shares in public circulation.
Many Wall Street Analysts have commented on AxoGen. Company shares were Reiterated by Wedbush on Aug 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 10 from a previous price target of $9 .